Cargando…
Dendrogenin A Enhances Anti-Leukemic Effect of Anthracycline in Acute Myeloid Leukemia
SIMPLE SUMMARY: Recently, several molecules have improved the clinical outcome of acute myeloid leukemia (AML) patients. Despite these recent advances, their prognosis remains poor and new strategies to improve the standard anthracycline and Ara-C-based chemotherapy are needed. We recently published...
Autores principales: | Mouchel, Pierre-Luc, Serhan, Nizar, Betous, Rémy, Farge, Thomas, Saland, Estelle, De Medina, Philippe, Hoffmann, Jean-Sébastien, Sarry, Jean-Emmanuel, Poirot, Marc, Silvente-Poirot, Sandrine, Récher, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601603/ https://www.ncbi.nlm.nih.gov/pubmed/33053669 http://dx.doi.org/10.3390/cancers12102933 |
Ejemplares similares
-
Dendrogenin A Synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo
por: Serhan, Nizar, et al.
Publicado: (2020) -
Dendrogenin A drives LXR to trigger lethal autophagy in cancers
por: Segala, Gregory, et al.
Publicado: (2017) -
Dendrogenin A and B two new steroidal alkaloids increasing neural responsiveness in the deafened guinea pig
por: Fransson, Anette, et al.
Publicado: (2015) -
Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties
por: de Medina, Philippe, et al.
Publicado: (2013) -
Targeting the liver X receptor with dendrogenin A differentiates tumour cells to secrete immunogenic exosome‐enriched vesicles
por: Record, Michel, et al.
Publicado: (2022)